Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02864316
Title Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Advanced Solid Tumor

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.